Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations (unaudited)

v3.24.2.u1
Statements of Operations (unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 2,009,102 $ 838,931 $ 3,609,843 $ 2,031,564
General and administrative 874,640 893,483 2,477,459 1,978,532
Total operating expenses 2,883,742 1,732,414 6,087,302 4,010,096
Loss from operations (2,883,742) (1,732,414) (6,087,302) (4,010,096)
Other income and expenses:        
Interest income, net 54,636 31,050 123,934 68,590
Net loss $ (2,829,106) $ (1,701,364) $ (5,963,368) $ (3,941,506)
Net loss per share of Common Stock, basic and diluted $ (4.18) $ (9.43) $ (10.64) $ (31.96)
Weighted-average basic and diluted Common Stock 676,567 180,332 560,282 123,344